| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/BMC.3274 |
| P698 | PubMed publication ID | 24961612 |
| P50 | author | Zhonglin Wei | Q80348500 |
| P2093 | author name string | Qin Meng | |
| Jian-yuan Yin | |||
| Cong Geng | |||
| De-ya Sun | |||
| Ji-hua Liu | |||
| Jing-yan Liu | |||
| Xiu-hua Yu | |||
| Yu-xia Yang | |||
| P2860 | cites work | HPLC determination of four active saponins from Panax notoginseng in rat serum and its application to pharmacokinetic studies | Q33207899 |
| Quantitative liquid chromatography/time-of-flight mass spectrometry | Q33283419 | ||
| Comparative analysis on microbial and rat metabolism of ginsenoside Rb1 by high-performance liquid chromatography coupled with tandem mass spectrometry | Q33326714 | ||
| Sensitive determination of 20(S)-protopanaxadiol in rat plasma using HPLC-APCI-MS: application of pharmacokinetic study in rats | Q33441402 | ||
| Analysis of Amisulpride in Human Plasma by SPE and LC with Fluorescence Detection | Q34538777 | ||
| Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy | Q35203734 | ||
| Ginsenoside-Rg1 mediates a hypoxia-independent upregulation of hypoxia-inducible factor-1α to promote angiogenesis | Q35544526 | ||
| Multi-faced neuroprotective effects of Ginsenoside Rg1 in an Alzheimer mouse model | Q35831048 | ||
| Fermenting red ginseng enhances its safety and efficacy as a novel skin care anti-aging ingredient: in vitro and animal study | Q36378880 | ||
| An integrated metabolomics and pharmacokinetics strategy for multi-component drugs evaluation | Q37714936 | ||
| Recent advances in metabolite identification and quantitative bioanalysis by LC-Q-TOF MS. | Q38005438 | ||
| Ginsenoside Rg3 attenuates tumor angiogenesis via inhibiting bioactivities of endothelial progenitor cells | Q39381863 | ||
| Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cord neurons in vitro | Q43873639 | ||
| Study of the neuroprotective effect of ginseng on superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) levels in experimental diffuse head trauma | Q44137364 | ||
| Pharmacokinetics and bioavailability of ginsenoside Rb1 and Rg1 from Panax notoginseng in rats | Q44369911 | ||
| Ultra-performance LC/TOF MS analysis of medicinal Panax herbs for metabolomic research. | Q45110368 | ||
| Liquid chromatography/tandem mass spectrometry for pharmacokinetic studies of 20(R)-ginsenoside Rg3 in dog. | Q45268294 | ||
| High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolites in rat plasma using solid-phase extraction for pharmacokinetic studies | Q45284713 | ||
| Simultaneous determination of notoginsenoside R1, ginsenoside Rg1, Re, Rb1 and icariin in rat plasma by ultra-performance liquid chromatography-tandem mass spectrometry. | Q45961076 | ||
| Studies on absorption, distribution and metabolism of ginseng in humans after oral administration | Q46161215 | ||
| Simultaneous rapid quantification of ginsenoside Rg1 and its secondary glycoside Rh1 and aglycone protopanaxatriol in rat plasma by liquid chromatography-mass spectrometry after solid-phase extraction | Q46501797 | ||
| Protective role of Panax ginseng extract standardized with ginsenoside Rg3 against acrylamide-induced neurotoxicity in rats. | Q46549039 | ||
| Simultaneous determination of ginsenoside Rg1, Re, Rd, Rb1 and ophiopogonin D in rat plasma by liquid chromatography/electrospray ionization mass spectrometric method and its application to pharmacokinetic study of 'SHENMAI' injection | Q46847539 | ||
| The antistress effect of ginseng total saponin and ginsenoside Rg3 and Rb1 evaluated by brain polyamine level under immobilization stress. | Q46985749 | ||
| Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional chinese medicine (TCM) in rats | Q47790486 | ||
| A new UPLC-MS/MS method for the determination of irinotecan and 7-ethyl-10-hydroxycamptothecin (SN-38) in mice: application to plasma and brain pharmacokinetics. | Q48536165 | ||
| Pharmacokinetics and tissue distribution study of scoparone in rats by ultraperformance liquid-chromatography with tandem high-definition mass spectrometry | Q48589000 | ||
| Anti-inflammatory mechanism of compound K in activated microglia and its neuroprotective effect on experimental stroke in mice | Q48740906 | ||
| Ginsenoside Re attenuates diabetes-associated cognitive deficits in rats | Q48751136 | ||
| Investigation of the disposition of loxapine, amoxapine and their hydroxylated metabolites in different brain regions, CSF and plasma of rat by LC-MS/MS. | Q48847148 | ||
| P433 | issue | 3 | |
| P304 | page(s) | 333-340 | |
| P577 | publication date | 2014-06-24 | |
| P1433 | published in | Biomedical Chromatography | Q4915104 |
| P1476 | title | Tissue distribution and excretion study of neopanaxadiol in rats by ultra-performance liquid chromatography quadrupole time-of-flight mass spectrometry | |
| P478 | volume | 29 |
Search more.